Autoplaque vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

Study Watch with Irregular Pulse Monitor (Home)

by Verily Health

AI Verdict

Tool A (Autoplaque) is designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. Tool B (Study Watch) is a wearable device focused on unobtrusive physiological data collection, including ECG and irregular pulse monitoring for AFib detection. While both leverage AI in cardiology, they serve distinct purposes: Autoplaque for diagnostic imaging analysis of structural heart disease, and Study Watch for continuous remote monitoring of cardiac rhythms.

Choose Autoplaque if…

Choose Autoplaque if you require detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses directly from CT angiography images. This workstation-based software is ideal for clinicians needing precise measurements and characterization of atherosclerotic plaque to inform heart attack risk prediction and guide treatment strategies.

View Autoplaque →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if your primary need is unobtrusive, long-term remote monitoring of physiological data, particularly for irregular pulse detection and on-demand single-channel ECG measurements. This prescription-only wearable is best suited for clinical research or healthcare scenarios where continuous, at-home cardiac rhythm data collection is crucial for early detection of conditions like AFib.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	Study Watch with Irregular Pulse Monitor (Home)
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	Unknown
FDA Status	Cleared AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Study Watch with Irregular Pulse Monitor (Home)

Tool B (Study Watch) is designed as an unobtrusive wearable for patients, making data collection passive and easy for the end-user. While Tool A (Autoplaque) offers a sophisticated workstation for clinicians, Tool B's patient-centric design for continuous, effortless data capture gives it an edge in broader usability.

Clinical Value

Autoplaque

Tool A (Autoplaque) provides a highly specific and quantitative AI-powered analysis of coronary plaques and luminal stenoses from CT angiography, directly aiding in heart attack risk prediction and treatment guidance. This offers immediate, actionable diagnostic insights for a critical condition.

Pricing & Value

Tie

Both Tool A (Autoplaque) and Tool B (Study Watch) have undisclosed pricing, making it impossible to conduct a head-to-head comparison of their value propositions. Without transparent cost information, a definitive winner cannot be determined.

Enterprise Readiness

Study Watch with Irregular Pulse Monitor (Home)

Tool B (Study Watch) leverages a cloud-based data processing model and explicitly states its ability to provide Business Associate Agreements (BAAs), indicating a scalable and enterprise-focused architecture. While Tool A is workstation-based, Tool B's cloud infrastructure is generally more adaptable for large-scale deployments and data management across an enterprise.

Innovation

Study Watch with Irregular Pulse Monitor (Home)

Tool B (Study Watch) demonstrates broader innovation through its integration of multiple physiological and environmental sensors, long battery life, and secure cloud-based analytics for continuous, unobtrusive data collection in a prescription-only wearable. This multi-modal, remote monitoring approach represents a significant advancement in patient data acquisition.

Support & Docs

Tie

Publicly available information regarding specific support channels and comprehensive documentation is limited for both Autoplaque and the Verily Study Watch. While Verily does offer some support resources for its broader platform, specific details for the Study Watch's direct users are not extensively detailed, leading to a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	Study Watch with Irregular Pulse Monitor (Home)
Name	Autoplaque	Study Watch with Irregular Pulse Monitor (Home)
Company	Cedars-Sinai Medical Center: AIM	Verily Life Sciences LLC
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
Primary Function	AI-powered quantitative analysis of atherosclerotic plaque and luminal stenoses from CT angiography images.	On-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose of each tool?

Autoplaque is an AI-powered software designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for unobtrusive collection of physiological data, including ECG and irregular pulse monitoring, primarily for atrial fibrillation (AFib) detection in clinical research and healthcare use.

How do the data input and output differ between Autoplaque and the Study Watch?

Autoplaque processes CT angiography images to provide AI-powered quantitative analysis of atherosclerotic plaque and luminal stenoses, with automated vessel, plaque, and lumen segmentation. The Study Watch collects physiological data via multiple sensors on a wearable device, offering on-demand single-channel ECG measurements and irregular pulse monitoring for AFib detection, with data processed in the cloud.

What are the data privacy and compliance considerations for each tool?

Verily states that its Study Watch services may be subject to HIPAA, and it may act as a 'business associate' for its customers, with on-device data encryption for security. However, a lawsuit alleging HIPAA breaches in past operations has been reported against Verily. Autoplaque's HIPAA compliance and whether it has a Business Associate Agreement (BAA) are not specified in the provided information.

Is a prescription required for either Autoplaque or the Study Watch?

The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device intended for use by healthcare professionals and adult patients with known or suspected heart conditions. Autoplaque is a prescription-use diagnostic reading software, but the information does not explicitly state a prescription is required for the software itself, rather it is used by trained medical professionals.

What specific cardiac conditions or risks do these tools help address?

Autoplaque focuses on the detection and characterization of coronary artery plaque and measurement of luminal stenoses from CT angiography images, aiding in heart attack risk prediction. The Study Watch is designed for irregular pulse monitoring, specifically for atrial fibrillation (AFib) detection, and can also collect data for other cardiovascular and movement disorders.